NCT06136546View on ClinicalTrials.gov

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 23, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

January 31, 2029

Conditions
Depressive Disorder, MajorInflammation
Interventions
DRUG

Infliximab

Intravenous infusion of infliximab

OTHER

Placebo

Intravenous infusion of saline solution (matching in color and consistency in infliximab)

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER